Effect of Pitavastatin on Carotid Arteries and Aorta Evaluated by Integrated Backscatter Trans-esophageal Ultrasound and PET/CT

Effect of Pitavastatin on Carotid Arteries and Aorta Evaluated by Integrated Backscatter Trans-esophageal Ultrasound and PET/CT - EPICENTRE study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002151

Enrollment

Registered

2009-07-01

Start date

2009-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dyslipidemia

Interventions

pitavastatin 2mg/day pravastatin 10mg/day

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with dyslipidemia who need to undergo trans-esophageal ultrasound because of atrial fibrillation or valvular disease

Exclusion criteria

Exclusion criteria: familial hypercholesterolemia severe hepatic disorder or biliary atresia malignancy collagen disease renal disorder (serum creatinine >= 2.0 mg/dl) uncontrolled diabetes

Design outcomes

Primary

Measure	Time frame
(1) Changes of SUV evaluated by PET/CT (2) Changes of integrated backscatter values	—

Secondary

Measure	Time frame
(1) Changes in lipid profile, intima-media thickness and inflammatory markers	—

Countries

Japan

Contacts

Public ContactMasanori Kawasaki

Gifu University Graduate School of Medicine Department of Cardiology

mkawa@gifu-u.ac.jp058-230-6523

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026